XRAY Stock Recent News
XRAY LATEST HEADLINES
DENTSPLY SIRONA Inc. (NASDAQ:XRAY ) Q1 2024 Results Conference Call May 2, 2024 8:30 AM ET Company Participants Andrea Daley - Vice President-Investor Relations Simon Campion - CEO, President & Director Glenn Coleman - Chief Financial Officer Andreas Frank - Executive Vice President & Chief Business Officer Conference Call Participants David Saxon - Needham & Company Jeff Johnson - Baird Dylan Finley - UBS Elizabeth Anderson - Evercore ISI Jason Bednar - Piper Sandler Jordan Bernstein - Stifel Sarah Conrad - Goldman Sachs Justin Lin - William Blair Allen Lutz - Bank of America Michael Petusky - Barrington Research Erin Wright - Morgan Stanley Operator Good day, everyone. And thank you for standing by.
DENTSPLY SIRONA's (XRAY) first-quarter 2024 results showcase a decline in year-over-year sales with an improved bottom line.
While the top- and bottom-line numbers for Dentsply (XRAY) give a sense of how the business performed in the quarter ended March 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Dentsply International (XRAY) came out with quarterly earnings of $0.42 per share, in line with the Zacks Consensus Estimate. This compares to earnings of $0.39 per share a year ago.
DENTSPLY SIRONA's (XRAY) first-quarter results are likely to reflect growth in the Wellspect Healthcare business and Orthodontic segment amid foreign exchange headwinds.
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
CHARLOTTE, N.C., April 09, 2024 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the "Company") (Nasdaq: XRAY) today announced that the Company will be hosting an investor conference call and live webcast on Thursday, May 2, 2024, at 8:30 am ET to review its first quarter financial results. A presentation related to the call will be available on the Investors section of the Company's website at https://investor.dentsplysirona.com.
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
DENTSPLY SIRONA (XRAY) continues to gain traction from a robust product portfolio. However, macroeconomic factors like weakened global demand, rising costs and forex woes persist.
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.